Literature DB >> 15571343

NIST mixed stain study 3: signal intensity balance in commercial short tandem repeat multiplexes.

David L Duewer1, Margaret C Kline, Janette W Redman, John M Butler.   

Abstract

Short-tandem repeat (STR) allelic intensities were collected from more than 60 forensic laboratories for a suite of seven samples as part of the National Institute of Standards and Technology-coordinated 2001 Mixed Stain Study 3 (MSS3). These interlaboratory challenge data illuminate the relative importance of intrinsic and user-determined factors affecting the locus-to-locus balance of signal intensities for currently used STR multiplexes. To varying degrees, seven of the eight commercially produced multiplexes used by MSS3 participants displayed very similar patterns of intensity differences among the different loci probed by the multiplexes for all samples, in the hands of multiple analysts, with a variety of supplies and instruments. These systematic differences reflect intrinsic properties of the individual multiplexes, not user-controllable measurement practices. To the extent that quality systems specify minimum and maximum absolute intensities for data acceptability and data interpretation schema require among-locus balance, these intrinsic intensity differences may decrease the utility of multiplex results and surely increase the cost of analysis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571343     DOI: 10.1021/ac049178k

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  2 in total

1.  Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity.

Authors:  Heather D Kissel; Patricia C Galipeau; Xiaohong Li; Brian J Reid
Journal:  Cancer Biomark       Date:  2009       Impact factor: 4.388

Review 2.  A Review of Probabilistic Genotyping Systems: EuroForMix, DNAStatistX and STRmix™.

Authors:  Peter Gill; Corina Benschop; John Buckleton; Øyvind Bleka; Duncan Taylor
Journal:  Genes (Basel)       Date:  2021-09-30       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.